M1

Chenyang Lu1, Rui-Juan Cheng2, Qiuping Zhang2

  • 1Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China; Division of Rheumatology, Department of Internal Medicine, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China.

PubMed
概括

塞法兰丁 (CEP) 通过抑制单细胞运动和促炎性巨细胞分化,减少了类风湿性关节炎 (RA) 模型中的关节炎和破坏. 这种药物显示出作为一种新型治疗RA的潜力.